Hart Blaine L, Taheri Saeid, Rosenberg Gary A, Morrison Leslie A
Department of Radiology, University of New Mexico, MSC10 5530, 1, Albuquerque, NM, 87131-0001, USA,
Transl Stroke Res. 2013 Oct;4(5):500-6. doi: 10.1007/s12975-013-0285-y. Epub 2013 Sep 21.
The aim of this study is to quantitatively evaluate the behavior of CNS cavernous malformations (CCMs) using a dynamic contrast-enhanced MRI (DCEMRI) technique sensitive for slow transfer rates of gadolinium. The prospective study was approved by the institutional review board and was HIPPA compliant. Written informed consent was obtained from 14 subjects with familial CCMs (4 men and 10 women, ages 22-76 years, mean 48.1 years). Following routine anatomic MRI of the brain, DCEMRI was performed for six slices, using T1 mapping with partial inversion recovery (TAPIR) to calculate T1 values, following administration of 0.025 mmol/kg gadolinium DTPA. The transfer rate (Ki) was calculated using the Patlak model, and Ki within CCMs was compared to normal-appearing white matter as well as to 17 normal control subjects previously studied. All subjects had typical MRI appearance of CCMs. Thirty-nine CCMs were studied using DCEMRI. Ki was low or normal in 12 lesions and elevated from 1.4 to 12 times higher than background in the remaining 27 lesions. Ki ranged from 2.1E-6 to 9.63E-4 min(-1), mean 3.55E-4. Normal-appearing white matter in the CCM patients had a mean Ki of 1.57E-4, not statistically different from mean WM Ki of 1.47E-4 in controls. TAPIR-based DCEMRI technique permits quantifiable assessment of CCMs in vivo and reveals considerable differences not seen with conventional MRI. Potential applications include correlation with biologic behavior such as lesion growth or hemorrage, and measurement of drug effects.
本研究的目的是使用对钆缓慢转移速率敏感的动态对比增强磁共振成像(DCEMRI)技术,对中枢神经系统海绵状畸形(CCM)的行为进行定量评估。该前瞻性研究已获得机构审查委员会的批准,并符合《健康保险流通与责任法案》(HIPPA)的要求。我们从14名患有家族性CCM的受试者(4名男性和10名女性,年龄22 - 76岁,平均48.1岁)处获得了书面知情同意书。在对大脑进行常规解剖磁共振成像后,静脉注射0.025 mmol/kg钆喷替酸葡甲胺后,使用部分反转恢复的T1映射(TAPIR)对六个层面进行DCEMRI检查以计算T1值。使用Patlak模型计算转移速率(Ki),并将CCM内的Ki与正常外观的白质以及先前研究的17名正常对照受试者进行比较。所有受试者的CCM均具有典型的磁共振成像表现。使用DCEMRI对39个CCM进行了研究。12个病灶的Ki较低或正常,其余27个病灶的Ki比背景高1.4至12倍。Ki范围为2.1E - 6至9.63E - 4 min⁻¹,平均为3.55E - 4。CCM患者中正常外观的白质平均Ki为1.57E - 4,与对照组白质平均Ki为1.47E - 4无统计学差异。基于TAPIR的DCEMRI技术允许在体内对CCM进行可量化评估,并揭示了传统磁共振成像未见的显著差异。潜在应用包括与病变生长或出血等生物学行为的相关性以及药物效果的测量。